Obesity

Showing NaN - NaN of 116

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Obesity Trial in Dallas (Doxorubicin, Cyclophosphamide)

Completed
  • Breast Cancer
  • Obesity
  • Dallas, Texas
    University of Texas Southwestern
Jul 24, 2018

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Birmingham, Alabama
  • +225 more
Dec 20, 2017

Type 2 Diabetes, Obesity Trial in Dallas (Liraglutide, Saline)

Completed
  • Type 2 Diabetes Mellitus
  • Obesity
  • Dallas, Texas
    UT Southwestern
Dec 15, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Vestavia Hills, Alabama
  • +160 more
Dec 6, 2017

Role of Pancreatic Triglyceride Content in Beta-cell Function

Completed
  • Obesity
  • Type 2 Diabetes
  • No intervention planned.
  • Dallas, Texas
    UT Southwestern Medical Center
Nov 29, 2017

Changes in Ectopic Fat Following Surgically Induced Weight Loss

Completed
  • Obesity
  • Type 2 Diabetes
    • Dallas, Texas
      University of Texas Southwestern
    Nov 17, 2017

    Obesity, Type 2 Diabetes Trial in Dallas (pioglitazone, )

    Completed
    • Obesity
    • Type 2 Diabetes
    • Dallas, Texas
      UT Southwestern Medical Center
    Nov 14, 2017

    Metabolism and Nutrition Disorder, Obesity Trial in Canada, United States (liraglutide, )

    Completed
    • Metabolism and Nutrition Disorder
    • Obesity
    • Goodyear, Arizona
    • +36 more
    Sep 29, 2017

    Metabolism and Nutrition Disorder, Obesity, Obstructive Sleep Apnoea Trial in Canada, United States (liraglutide, )

    Completed
    • Metabolism and Nutrition Disorder
    • +2 more
    • Glendale, California
    • +41 more
    Sep 29, 2017

    Obesity, Rhinitis, Rhinitis, Allergic Trial in Dallas (dietary supplement, other, device)

    Terminated
    • Obesity
    • +11 more
    • Vitamin A
    • +11 more
    • Dallas, Texas
      Verifomics, LLC
    Sep 27, 2017

    Obesity Trial in Dallas (Vevazz LED)

    Completed
    • Obesity
    • Vevazz LED
    • Dallas, Texas
      Vevazz, LLC
    Aug 3, 2017

    Obesity, Pharmacokinetics, MRSA Trial in Dallas (Sulfamethoxazole/trimethoprim)

    Completed
    • Obesity
    • +4 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    May 17, 2017

    Obesity, Overweight Trial in United States (NB32, PBO, Weight Management Program)

    Terminated
    • Obesity
    • Overweight
    • Birmingham, Alabama
    • +223 more
    Feb 24, 2017

    Obesity, Cardiovascular Diseases Trial in United States (Naltrexone HCl/Bupropion HCl ER, Placebo)

    Terminated
    • Obesity
    • Cardiovascular Diseases
    • Naltrexone HCl/Bupropion HCl ER
    • Placebo
    • Alexander City, Alabama
    • +138 more
    Feb 21, 2017

    Obesity, Fungal Infection Trial in Dallas (Caspofungin)

    Completed
    • Obesity
    • Fungal Infection
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Dec 21, 2016

    Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)

    Terminated
    • Type 2 Diabetes
    • Obesity
    • EndoBarrier
    • Sham Procedure
    • Birmingham, Alabama
    • +24 more
    Dec 2, 2016

    Obesity Trial in United States (Transoral Suturing, Sham Endoscopy)

    Terminated
    • Obesity
    • Transoral Suturing
    • Sham Endoscopy
    • Denver, Colorado
    • +9 more
    Aug 12, 2016

    Obesity, Leprosy, Tuberculosis Trial in Dallas (Dapsone)

    Completed
    • Obesity
    • +2 more
    • Dallas, Texas
      University of Texas Southwestern
    Jun 9, 2016

    Obesity, Overweight Trial in United States (NB, CLI, Usual Care)

    Completed
    • Obesity
    • Overweight
    • Denver, Colorado
    • +14 more
    Nov 30, 2015

    Obesity Trial in United States (Placebo, Pramlintide and Metreleptin)

    Completed
    • Obesity
    • Placebo
    • Pramlintide and Metreleptin
    • Birmingham, Alabama
    • +32 more
    Mar 26, 2015

    Overweight, Obesity Trial in United States (pramlintide acetate, metreleptin, -P)

    Completed
    • Overweight
    • Obesity
    • pramlintide acetate
    • +3 more
    • Birmingham, Alabama
    • +35 more
    Mar 26, 2015

    Obesity Trial in Puerto Rico, United States (exenatide, )

    Completed
    • Obesity
    • Peoria, Arizona
    • +15 more
    Mar 19, 2015

    Obesity, Overweight, Diabetes, Type 2 Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/ day, Placebo, Ancillary

    Completed
    • Obesity
    • +2 more
    • Naltrexone SR 32 mg/bupropion SR 360 mg/ day
    • +2 more
    • Fairhope, Alabama
    • +52 more
    Nov 18, 2014

    Obesity, Overweight Trial in United States (Naltrexone SR 16 mg/Bupropion SR 360 mg /day, Naltrexone SR 32 mg/Bupropion SR 360

    Completed
    • Obesity
    • Overweight
    • Naltrexone SR 16 mg/Bupropion SR 360 mg /day
    • +3 more
    • Birmingham, Alabama
    • +33 more
    Nov 18, 2014